
    
      This RCT compares two doses of zonisamide and placebo for one year. A total of 225 subjects
      are randomly assigned to one of the three treatment interventions at Duke University Medical
      Centre. The primary outcome measure is change in body weight in kilograms. Secondary outcomes
      include changes in waist circumference, glycaemic and inflammatory markers, lipids, food
      craving, hunger and satiety, quality of life, blood pressure and heart rate.
    
  